Fundai

Aveh Sina Pharmaceutical Company (DAVE) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DAVE
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations257,502459,378209,587412,64755,761-143,914
Cash payments for income tax-82,604-13,916-11,382-41,467-15,206-16,380
Net cash inflow (outflow) from operating activities174,898445,462198,205371,18040,555-160,294
Cash payments for purchase of property, plant and equipment-91,549-26,035-6,689-12,968-30,224-9,632
Cash payments for purchase of intangible assets-3,330-519-11,932-3,6390-6
Cash receipts from interest on other investments6215016089272,0311,203
Net cash inflow (outflow) from investing activities-94,258-26,053-18,013-14,099-28,19351,565
Net cash inflow (outflow) before financing activities80,640419,409180,192357,08112,362-108,729
Cash receipts from facilities936,180326,296527,832243,891435,300615,300
Cash payments for principal of loans-588,323-483,579-565,549-590,708-399,476-372,298
Cash payments for interest on loans-79,137-44,780-64,598-49,977-58,928-29,168
Cash payments for dividends-4220-10,695-318-24,432-3,096
Net cash inflow (outflow) from financing activities268,298-202,063-113,010-397,112-47,536210,738
Net increase (decrease) in cash348,938217,34667,182-40,031-35,174102,009
Cash balance at beginning of year630,341111,33255,158108,69769,56244,470
Effect of changes in exchange rates745151163227117250
Cash balance at end of year980,024328,829122,50368,89334,505146,729

Reporting periods

35 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.